
























































































































































































































































































ENM Cytotoxicity mechanism Design features to mitigate toxicity 
TiO2  •  Electron/hole-pair ROS production 
•  Glutathione depletion and toxic  
   oxidative stress  •  Iron-doping to slow dissolution 
•  Capping with surfactants, polymers or    
   complexing ligands 
•  Coating with low-molecular-weight  
    antioxidants 
•  Altered chemical composition that, for  
   example, eliminates crystalline states and  
   material defects (e.g., rutile in place of   
   anatase TiO2) 
ZnO •  ROS generation 
•  Dissolution and Zn++ release  
•  Lysosomal damage 
• I nflammation 
Ag NPs •  Dissolution and Ag+ release 
•  ROS production 
•  Disrupt membrane integrity and    
  transport processes 
CdSe •  Dissolution and release of Cd and Se  
  ions  
•  Coating the toxic core with biocompatible  
   polymers/inorganic shells 
SiO2 and quartz 
(crystalline silica) 
•  ROS generation by surface  
   hydroxyls/impurities 
•  Membrane disruption  
•  Particle aggregation or modification of size 
   and/or surface charge 
•  Surface modification with aluminium  
  lactate or polyvinylpyridine N-oxide 
Magnetite, Fe3O4 •  ROS production and oxidative stress 
•  Liberation of toxic Fe2+ 
•  Disturbance of electronic and/or ion  
   transport in cell membrane 
•  Fuctionalization with biocompatible shell 














Regarded  as 










with reasonably safe 
consumer profile; 
inadvertent  lung 
exposure leads to 
metal fume fever 
Modest risk to 
workers and 
consumers but 












risk uncertain but 





+ regarded as 








Relatively high based 
on analogy to 
asbestos 
Sunscreen 
ingredient but no 
clinical data 
indicating toxicity 
Same as for TiO2 in 
sunscreens; Does it 
reach the 
environment and in 
what quantities? 
High perceptual 





Under TSCA, CNT are 
new chemicals 
requiring a  PMN.  
EPA regulating with 
consent order/SNUR. 
Existing chemical 
under TSCA.   EPA  
developing a SNUR 
for nano forms of 
existing chemicals. 
Existing chemical 
under TSCA. EPA  
developing a SNUR 
for nano forms of 
existing chemicals. 













































































































•  Known Adverse Health Effects 
From Existing Literature 
•  Known Adverse Environmental 
Effects From Existing Literature 
Hazard/
Toxicity Score 
•  California Production Volumes 
•  Main California Industries 
•  Product Use 
•  California Commerce and Patent Data 
•  Lux Research Data 
Use/Exposure 
Score 
Prioritization 
Outcome 
NSF: EF‐0830117 
Some Insights from Preliminary Analysis of DTSC Call‐In 
•  11 of the 22 respondents were Universi6es, Na6onal Laboratories, or 
University‐aﬃliated research centers. 
• Analysis of responses to ques6on  how to phrase ques6ons for 
future call‐ins on other ENMs 
• Analysis of literature plus leters  large gaps in available informa6on 
needed for life cycle assessment (e.g., value chain) 
•  Good news: many organiza6ons reported good prac6ces in terms of 
use and waste protocols for CNTs 
•  Bad news: there appears to be large diﬀerences between 
respondents in: 
•  knowledge about CNTs’ eﬀects on health and the environment 
•  views on how to safely handle CNTs in the workplace. 

NSF: EF‐0830117 
Training Module on Safe Handling and Disposal of 
Nanomaterials for Laboratory Workers 
•  Interac6ve content in case‐study 
format 
•  Includes best prac6ces derived from 
NIOSH and Department of Energy 
recommenda6ons 
•  Will be tested for eﬃcacy, modiﬁed as 
appropriate, disseminated to CEIN 
partner ins6tu6ons 
•  Goal to launch test: September 2010 
NSF: EF‐0830117 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